chartexchange
EDTUTC-4 New York
Sign up
FeedbackDocs

NGNE
Neurogene, Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 3:59:57 PM EDT
25.60USD-3.578%(-0.95)401,641
Loading…
Loading…
Market Cap
511.79M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Previous Close
$26.55
Beta
1.48
52-Week High
$43.66 2026-07-09
52-Week Low
$15.93 2026-02-05
SMA 50
$34.76
SMA 200
$27.22
Avg. Vol 10D
349,746
Avg. Vol 30D
304,470
Avg. Vol 90D
247,854
Relative Vol
1.32
Shares Out
20.01M
Float
12.54M
Free Float %
62.65%
Short Interest
3,280,172
Short Interest %
26.16%
Days to Cover
16.85
On/Off Exchange
50%/50%
Short Vol %
69.08%
Short Vol % (off-exch)
43.73%
Borrow Fee
0.4100%
Borrow Avail.
85,000
FTDs
117
FTDs 30d avg
288
FTDs 30d high
1,238
Next Earnings
Nov 12, 2026 (38d)
NGNE Profile

neoleukin therapeutics, inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. the company's lead product candidate is nl-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (il)-2/il-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. the company was formerly known as aquinox pharmaceuticals, inc. and changed its name to neoleukin therapeutics, inc. in august 2019. neoleukin therapeutics, inc. was founded in 2003 and is headquartered in seattle, washington.

NGNE Performance
PeriodPriceDateChangeBeta
1W28.482026-09-28-10.20%-2.552
1M38.602026-09-04-33.74%-0.574
3M32.562026-07-06-21.45%0.162
6M20.472026-04-06+24.94%1.068
1Y22.342025-10-03+14.48%1.479
2Y48.592024-10-04-47.37%—
NGNE Stock Summary

Neurogene, Inc. Common Stock (NASDAQ:NGNE) stock price today is $25.58, and today's volume is 401,641. NGNE is down 3.672% today. The 30 day average volume is 304,470. NGNE market cap is $511.79M with 20.01M shares outstanding.